Malignant Melanoma Completed Phase 1 / 2 Trials for Paclitaxel (DB01229)
Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS (morphologic abnormality) / Melanoma / Malignant melanoma (morphologic abnormality) / Malignant melanoma (disorder) / [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS / Melanoma: [skin] or [malignant] / Melanoma malignant
| Indication | Status | Phase |
|---|---|---|
| DBCOND0029825 (Malignant Melanoma) | Completed | 1 / 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01962103 | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors | Treatment |